Mirella Ezban

7PUBLICATIONS
4CO-AUTHORS
Medical virologyMedical molecular engineering of nucleic acids and proteinsMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 14, 2025
Factor VIII Activity and Factor VIII Inhibitors Can Be Measured Accurately in Plasma Containing Mim8 by Using Specific Chromogenic Assays.

William Pickering, Mary Robinson, Caroline Cogswell

|Oct 12, 2023
A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non-factor VIII related haemostasis assays.

Annette Elizabeth Bowyer, Kieron Hickey, Steve Kitchen

|Dec 14, 2020
Measuring factor VIII activity in samples from patients treated with N8-GP (Esperoct® ; turoctocog alfa pegol) during the pathfinder clinical trials programme.

Judi Møss, Wan Hui Ong Clausen, Mirella Ezban

|Dec 07, 2019
An overview of turoctocog alfa pegol (N8-GP; ESPEROCT® ) assay performance: Implications for postadministration monitoring.

Mirella Ezban, Martin Hansen, Marianne Kjalke

|Jul 12, 2019
A field study evaluating the activity of N8-GP in spiked plasma samples at clinical haemostasis laboratories.

Stefan Tiefenbacher, Wan Hui Ong Clausen, Martin Hansen

|Jun 01, 2019
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding.

Junjiang Sun, Eric W Livingston, Mie L Broberg

Pageof 2

Frequent Collaborators

1 joint publications

Junjiang Sun

1 joint publications

Carsten D Ley

1 joint publications

Tom Knudsen

1 joint publications

Annette Elizabeth Bowyer